End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration

R Gidwani, SM Asch, J Needleman… - Journal of the …, 2021 - Wiley Online Library
BACKGROUND/OBJECTIVES To evaluate differences in end‐of‐life cost trajectories for
cancer patients treated through Medicare versus by the Veterans Health Administration (VA) …
被引用次数：3 相关文章

End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.

R Gidwani, SM Asch, J Needleman… - Journal of the …, 2021 - search.ebscohost.com
BACKGROUND/OBJECTIVES To evaluate differences in end‐of‐life cost trajectories for
cancer patients treated through Medicare versus by the Veterans Health Administration (VA) …

End-of-Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration.

R Gidwani, SM Asch, J Needleman… - Journal of the …, 2020 - europepmc.org
Design A retrospective analysis of VA and Medicare administrative data from FY 2010 to
2014. We employed three-level generalized estimating equations to evaluate monthly cost …
[PDF] google.com

[PDF][PDF] End‐of‐Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration

R Gidwani, SM Asch, J Needleman… - Journal of the …, 2021 - drive.google.com
BACKGROUND/OBJECTIVES: To evaluate differences in end-of-life cost trajectories for
cancer patients treated through Medicare versus by the Veterans Health Administration (VA) …

End-of-Life Cost Trajectories in Cancer Patients Treated by Medicare versus the Veterans Health Administration

R Gidwani, SM Asch, J Needleman… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background/objectives To evaluate differences in end-of-life cost trajectories for cancer
patients treated through Medicare versus by the Veterans Health Administration (VA) …